Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Burhan Ferhanoğlu Firat Yalniz Nükhet Tüzüner Tugrul Elverdi Ahmet Emre Eskazan Muhlis Cem Ar |
| Publication date | April 18, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |